Bionano Genomics Inc Financial Flexibility Index
Bionano Genomics Inc financial flexibility index. Bionano Genomics Inc (BNGO) has a Financial Flexibility Index of -0.29x as of June 2026. Free cash flow of $-4.67 Million (operating CF $-4.67 Million minus capex $0.00) represents 0% of total liabilities ($15.98 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bionano Genomics Inc (2016–2025)
Financial flexibility index of Bionano Genomics Inc from 2016 to 2025. Historical Financial Flexibility Index trend for Bionano Genomics Inc across 10 annual periods. Explore Bionano Genomics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Bionano Genomics Inc Financial Flexibility Index by Year (2016–2025)
Bionano Genomics Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Bionano Genomics Inc. For the full cash flow conversion analysis, see BNGO cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-16.34 Million | $-16.34 Million | $29.16 Million | ▲ +66.4% |
| 2024 | -1.67x | $-68.82 Million | $-68.92 Million | $41.30 Million | ▼ -59.6% |
| 2023 | -1.04x | $-123.49 Million | $-125.18 Million | $118.25 Million | ▲ +50.1% |
| 2022 | -2.09x | $-121.51 Million | $-124.82 Million | $58.10 Million | ▼ -18.7% |
| 2021 | -1.76x | $-70.47 Million | $-71.93 Million | $39.98 Million | ▼ -32.8% |
| 2020 | -1.33x | $-33.66 Million | $-38.31 Million | $25.37 Million | ▼ -19.7% |
| 2019 | -1.11x | $-29.47 Million | $-29.53 Million | $26.59 Million | ▲ +17.1% |
| 2018 | -1.34x | $-19.61 Million | $-19.94 Million | $14.67 Million | ▼ -307.8% |
| 2017 | -0.33x | $-19.80 Million | $-20.82 Million | $60.37 Million | ▲ +37.7% |
| 2016 | -0.53x | $-22.15 Million | $-23.50 Million | $42.05 Million | — |